Results for untargeted MS search on m/z: (+/-) mode
Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
---|---|---|---|---|---|---|---|---|---|---|
AN001063 | 72.0213 | 1.5 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 86.0374 | 1.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 90.0316 | 0.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 112.0162 | 1.01 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 112.0270 | 0.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 115.9956 | 0.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 116.0111 | 1.24 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 116.9282 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 117.0423 | 1.17 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 118.0267 | 1.29 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 118.0628 | 1.63 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 126.0317 | 1.54 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 129.0423 | 1.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 130.0276 | 1.14 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 130.0629 | 4.41 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 131.0586 | 1.49 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 133.9305 | 24.61 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 134.0216 | 0.78 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 135.0540 | 3.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 135.0671 | 5.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 135.8998 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 136.0369 | 0.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 138.0442 | 5.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | L-[15N]ANTHRANILIC ACID [ISTD] (CAS# ); (M-H)- | 138.0444 | 5.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001063 | 139.0268 | 7.03 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 144.0422 | 1.57 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 145.0737 | 1.28 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 147.0533 | 0.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 147.0894 | 3.29 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 148.0371 | 1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 149.9568 | 0.5 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 159.9856 | 0.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 161.0687 | 1.25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 161.8492 | 0.7 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 162.0528 | 1.63 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 165.0787 | 2.53 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 171.0525 | 1.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 171.8399 | 0.48 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 173.0689 | 1.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 174.0167 | 1.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 175.0482 | 0.94 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 175.0838 | 1.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 176.0431 | 0.74 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 179.0581 | 5.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | D-MANNOSAMINE (CAS# 14307-02-9); (M-H)-[-H2O] | 179.0792 | 0.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001063 | 182.0575 | 3.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 183.0200 | 1.06 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 189.0639 | 1.28 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 191.0615 | 4.09 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 192.0271 | 1.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 192.0885 | 2.53 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 193.0396 | 1.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 193.0560 | 12.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 193.0735 | 5.65 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 194.0315 | 1.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 195.0895 | 17.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 196.0031 | 5.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 197.0687 | 1.35 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 201.0633 | 1.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 201.1013 | 3.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 202.0952 | 1.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 204.0897 | 3.61 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 206.0319 | 5.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 206.0427 | 1.53 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 206.0835 | 3.61 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | L-TRYPTOPHAN-15N2 [ISTD] (CAS# ); (M-H)- | 206.0835 | 3.62 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001063 | 210.1258 | 13.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 212.1412 | 14.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 216.0439 | 0.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 217.0579 | 1.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 218.0474 | 0.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 218.0897 | 1.05 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 219.0744 | 1.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 219.1108 | 3.29 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 219.1122 | 3.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 220.0525 | 1.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 220.8528 | 3.74 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 224.9807 | 8.53 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 226.9337 | 5.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 234.0848 | 0.7 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 241.0587 | 1.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 243.1834 | 15.84 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 245.0536 | 1.22 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 246.0510 | 0.67 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 246.1213 | 2.5 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 247.0689 | 1.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 250.9425 | 1.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 251.9484 | 1.63 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 256.2401 | 22.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 257.0665 | 0.69 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 258.0847 | 1.46 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 260.1370 | 4.62 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 262.0788 | 0.95 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 262.9097 | 5.35 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 263.0770 | 17.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 265.2964 | 22.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 266.9053 | 5.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 268.0843 | 13.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 272.0649 | 1.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 273.0960 | 0.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 273.1314 | 2.57 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 273.9661 | 0.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 274.0192 | 5.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 276.0295 | 0.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 276.0453 | 1.62 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 276.0627 | 0.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 276.0952 | 1.28 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 277.0692 | 3.29 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 278.1133 | 13.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 278.1295 | 5.38 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 278.1520 | 21.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 280.0606 | 0.65 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 280.0660 | 1.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 282.1074 | 3.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 282.2557 | 22.91 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 284.2716 | 23.17 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 286.9181 | 3.2 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 287.0977 | 3.3 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 288.0593 | 0.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 289.0606 | 0.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 289.1265 | 1.62 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 289.1268 | 1.21 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 289.8843 | 1.2 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 289.9430 | 2.53 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 290.0263 | 0.78 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 290.0456 | 1.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 290.1082 | 12.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 290.9513 | 2.53 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 296.0889 | 0.65 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 298.0703 | 5.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 303.0594 | 1.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 304.0904 | 1.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 304.2402 | 22.69 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 306.0533 | 1.65 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 306.9225 | 3.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 307.0812 | 1.54 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 307.0841 | 0.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 307.9998 | 3.3 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 309.1050 | 0.73 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 310.9999 | 3.29 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 315.9265 | 4.09 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 316.9340 | 4.09 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 317.9052 | 1.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 318.1060 | 1.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 321.0696 | 1.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 321.0697 | 1.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 322.0673 | 1.5 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 322.9198 | 5.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 324.0361 | 0.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 324.0885 | 0.65 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 324.2276 | 22.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 324.8904 | 3.2 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 326.0721 | 1.44 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 326.1023 | 0.64 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 326.1919 | 22.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 326.1920 | 22.91 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 329.0009 | 5.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 329.9625 | 3.61 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 330.1829 | 13.41 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 331.1377 | 2.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 333.0659 | 4.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 333.1050 | 3.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 334.0983 | 12.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | NICOTINIC ACID MONONUCLEOTIDE (CAS# ); (M-H)- | 335.0393 | 0.76 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001063 | 336.1556 | 5.61 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 337.1398 | 10.38 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 339.8997 | 5.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 341.9813 | 3.3 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 343.0517 | 1.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 343.0943 | 4.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 346.0856 | 1.63 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 346.1001 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 346.1416 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 346.9794 | 3.29 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 347.9706 | 3.29 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 348.0529 | 0.95 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 348.0822 | 0.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 349.0939 | 1.53 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 349.0944 | 2.16 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 351.9031 | 4.09 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 352.2592 | 23.17 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 354.0559 | 15.09 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 354.1004 | 0.64 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 356.1643 | 22.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 360.1936 | 13.42 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 365.1249 | 1.64 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 365.2216 | 22.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 366.9262 | 3.63 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 368.1153 | 0.64 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 370.1280 | 0.64 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 371.0750 | 2.16 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 378.0940 | 0.73 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 378.2795 | 22.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 379.1047 | 2.07 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 379.9523 | 3.3 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 379.9534 | 3.88 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 383.1080 | 3.62 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 384.1209 | 1.5 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 384.1963 | 23.17 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 386.1317 | 3.3 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 386.1337 | 3.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 388.1632 | 21.89 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 392.0575 | 12.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 392.2949 | 22.91 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 392.2952 | 22.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 394.1208 | 13.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 399.1290 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 399.2409 | 22.79 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 401.2703 | 22.82 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 402.0625 | 1.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 402.0862 | 12.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 404.1001 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 404.3113 | 22.92 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 408.0709 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 408.1573 | 3.85 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 409.9647 | 1.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 410.3183 | 23.28 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 414.0886 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 414.1289 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 415.1074 | 3.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 421.9542 | 4.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 423.0958 | 1.2 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 427.0291 | 0.76 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 428.9565 | 1.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 437.1220 | 0.73 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 442.2330 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 445.9403 | 1.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 446.1919 | 21.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 447.3838 | 23.82 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 448.1425 | 0.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 448.9476 | 1.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 449.4426 | 23.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 450.1118 | 1.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 458.2315 | 22.93 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 459.1584 | 0.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 460.2006 | 3.29 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 460.2072 | 21.71 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 469.1358 | 1.2 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 470.0731 | 12.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 472.0861 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 474.1864 | 13.42 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 474.2891 | 25.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 474.4062 | 24.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 476.0563 | 13.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 478.1287 | 21.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 479.3002 | 22.28 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 482.0748 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 482.1159 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 487.2856 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 490.1038 | 1.05 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 492.1446 | 21.71 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 492.3652 | 24.08 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 496.3396 | 18.91 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 501.2850 | 21.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 504.2029 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 506.9889 | 4.09 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 508.2247 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 510.2183 | 13.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 513.1631 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 514.1788 | 21.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 515.2827 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 516.3214 | 19.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 518.1619 | 3.29 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 519.3924 | 26.56 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 523.1002 | 12.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 525.2842 | 22 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 526.3504 | 19.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 527.2152 | 13.4 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 527.3005 | 22.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 528.1942 | 21.71 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 529.3168 | 22.37 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 531.2781 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 532.3162 | 18.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 535.1449 | 8.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 537.5123 | 24.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 538.0577 | 12.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 541.0607 | 1.04 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 542.3447 | 18.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 542.3451 | 18.91 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 544.0388 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 544.0849 | 8.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 545.4568 | 23.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 550.0601 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 550.1025 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 553.5070 | 24.07 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 555.4863 | 23.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 557.2271 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 559.4723 | 24.09 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 563.2977 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 566.0537 | 0.79 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 568.0937 | 1.32 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 569.2732 | 21.98 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 569.4983 | 24.09 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 571.4733 | 23.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 571.4806 | 24.07 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 571.5170 | 24.42 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 572.1905 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 575.5034 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 576.1494 | 21.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 576.4892 | 24.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 578.2064 | 13.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 580.0335 | 1.25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 580.0338 | 1.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 581.5015 | 23.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 582.1654 | 21.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 582.5316 | 25.01 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 583.5178 | 24.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 583.5180 | 24.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 585.5313 | 24.75 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 585.5323 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 589.0815 | 0.92 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | GUANOSINE 5'-DIPHOSPHO-BETA-L-FUCOSE (CAS# 0); (M-H)- | 589.0817 | 0.92 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001063 | 590.1588 | 22.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 593.2711 | 21.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 594.3366 | 19.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 594.3369 | 19.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 595.2875 | 22.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 596.1812 | 21.71 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 597.3043 | 22.37 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 597.5327 | 24.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 599.2164 | 22.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 600.5083 | 24.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 603.1315 | 8.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 607.0806 | 1.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 607.0811 | 0.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 608.1793 | 1.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 609.5291 | 24.55 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 610.3315 | 17.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 610.3321 | 18.91 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 611.5488 | 25.04 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | GLUTATHIONE (CAS# 27025-41-8); (M-H)- | 612.1516 | 1.32 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001063 | 612.1516 | 1.32 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 618.0898 | 8.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 618.1906 | 23.17 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 628.2905 | 18.91 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 629.0627 | 0.77 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 630.1618 | 1.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 634.1317 | 1.3 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 636.1488 | 0.95 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 637.2600 | 21.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 637.4884 | 24.09 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 637.5993 | 26.5 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 640.1775 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 646.1926 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 647.1407 | 1.42 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 647.3659 | 19.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 649.4886 | 23.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 650.1541 | 21.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 651.5044 | 24.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 652.1272 | 0.95 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 653.5157 | 24.62 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 661.2570 | 21.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | NAD (CAS# 53-84-9); (M-H)- | 663.1077 | 1.03 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001063 | 663.1081 | 1.03 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 663.2745 | 22.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 663.6159 | 26.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 664.1187 | 1.37 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 665.1241 | 1.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 665.2914 | 22.37 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 665.6313 | 22.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 667.2015 | 22.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 667.4994 | 24.07 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 671.1170 | 8.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 673.5050 | 24.46 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 674.3356 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 675.5192 | 24.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 679.5346 | 25.03 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 680.0932 | 1.38 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 681.5826 | 26.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 681.5908 | 25.74 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 682.4341 | 24.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 683.1334 | 1.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 683.6048 | 26.5 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 685.4616 | 24.06 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 685.6125 | 24.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 685.6125 | 24.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 686.1771 | 23.17 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 687.1047 | 1.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 687.5201 | 24.78 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 689.5021 | 24.23 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 691.5220 | 24.62 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 691.6105 | 26.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 691.6111 | 26.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 692.2825 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 695.6417 | 24.21 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 697.5059 | 24.37 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 697.6562 | 25.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 699.5211 | 24.67 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 699.5640 | 23.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 699.9169 | 23.17 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 701.5356 | 25.12 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 701.6080 | 22.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 703.5212 | 24.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 703.5573 | 25.28 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 704.5382 | 24.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 705.2477 | 21.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 707.6053 | 25.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 708.1635 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 709.5064 | 24.3 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 709.6224 | 26.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 711.5195 | 24.7 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 712.1236 | 21.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 713.5013 | 24.03 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 714.1793 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 714.2645 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 715.5148 | 24.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 715.5592 | 23.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 717.5303 | 24.78 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 717.5381 | 23.48 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 718.1391 | 21.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 719.5464 | 25.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 720.5397 | 23.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 721.5063 | 24.26 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 721.6557 | 24.42 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 723.5205 | 24.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 724.1466 | 8.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 725.5355 | 24.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 725.5382 | 25.04 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 725.6507 | 24.14 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 726.1335 | 22.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 727.5515 | 25.3 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 729.2462 | 22 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 729.5375 | 24.55 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 729.5698 | 26.04 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 731.2629 | 22.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 731.5538 | 23.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 733.2798 | 22.37 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 733.5049 | 24.23 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 735.1905 | 22.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 735.5273 | 24.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 736.3103 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 737.5367 | 24.84 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 737.5587 | 24.63 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 738.5399 | 23.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 739.5143 | 24.32 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 739.5495 | 25.22 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 741.5282 | 24.65 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 741.5285 | 24.49 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 742.3239 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 743.0703 | 0.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 743.5457 | 24.92 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 743.5525 | 23.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE (CAS# 5502-96-5); (M-H)- | 744.0633 | 1.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
AN001063 | 745.5613 | 25.57 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 746.5567 | 23.71 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 747.5208 | 24.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 747.5216 | 24.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 748.5744 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 749.5252 | 23.79 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 749.5366 | 24.75 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 750.5765 | 24.24 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 751.5359 | 24.1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 751.5474 | 24.84 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 751.5507 | 25.33 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 751.5508 | 25.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 751.5919 | 26.5 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 753.5313 | 24.62 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 753.5664 | 25.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 754.1655 | 23.17 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 755.5441 | 24.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 757.4867 | 24.24 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 757.5601 | 25.3 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 759.5846 | 24.08 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 759.5994 | 26.74 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 759.6003 | 26.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 759.6022 | 26.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 761.0839 | 1.05 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 761.5206 | 25.69 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 761.5349 | 24.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 763.5162 | 24.25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 763.5202 | 24.16 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 763.5608 | 25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 763.5706 | 24.67 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 763.6255 | 24.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 763.6275 | 24.2 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 765.5316 | 24.44 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 765.5325 | 24.45 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 765.5348 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 765.5650 | 25.58 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 765.5873 | 25.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 767.5411 | 24.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 767.5464 | 24.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 769.5467 | 25.14 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 769.5514 | 26.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 769.5598 | 25.28 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 769.5611 | 25.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 771.5176 | 24.27 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 771.5752 | 25.74 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 771.6221 | 24.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 773.2349 | 21.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 773.5354 | 24.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 773.5985 | 24.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 775.5374 | 23.92 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 775.5511 | 24.85 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 775.5526 | 25.22 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 775.5870 | 25.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 777.5514 | 24.26 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 777.5653 | 25.31 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 777.5673 | 25.5 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 777.6048 | 26.94 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 777.6079 | 26.69 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 779.5660 | 24.67 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 779.5820 | 26.07 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 779.6219 | 22.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 781.5643 | 24.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 782.2519 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 783.5040 | 24.33 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 783.5686 | 25.33 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 783.5817 | 25.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 785.5175 | 24.78 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 787.5145 | 24.03 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 788.5298 | 23.61 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 789.5305 | 24.37 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 789.5506 | 26.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 789.5811 | 25.16 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 789.5847 | 24.79 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 789.9809 | 23.17 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 789.9811 | 23 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 791.5183 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 791.5465 | 24.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 791.6029 | 25.31 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 793.5533 | 25.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 793.5603 | 25.05 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 793.5607 | 25.1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 793.5767 | 25.31 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 793.6028 | 26.09 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 795.5530 | 24.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 795.5664 | 26.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 795.5743 | 25.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 797.5647 | 26.03 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 797.5829 | 22.83 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 797.6285 | 24.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 799.6520 | 25.57 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 801.5498 | 24.06 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 801.6297 | 25.01 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 803.5664 | 24.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 804.2976 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 805.5827 | 24.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 806.5334 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 807.5978 | 25.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 809.5143 | 24.53 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 810.3141 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 811.5335 | 24.92 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 811.5337 | 26.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 811.5669 | 24.61 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 811.6471 | 25.24 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 811.6479 | 25.35 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 813.5493 | 25.56 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 813.5521 | 26.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 813.5571 | 23.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 813.5842 | 24.75 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 813.6667 | 26.08 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 814.5442 | 23.71 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 815.5105 | 24.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 815.6017 | 25.06 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 816.5601 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 817.5102 | 23.79 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 817.5318 | 24.75 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 817.6164 | 25.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 818.5650 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 818.5651 | 24.24 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 819.5244 | 24.1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 819.5467 | 25.33 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 819.5495 | 25.33 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 819.5539 | 25.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 819.6315 | 26.32 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 819.6323 | 25.9 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 821.5266 | 24.62 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 821.5545 | 25.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 821.5648 | 25.98 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 823.4498 | 24.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 823.6481 | 25.1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 825.5506 | 24.01 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 825.6674 | 25.89 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 825.6679 | 25.69 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 825.6689 | 25.69 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 827.5630 | 24.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 827.5647 | 24.08 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 827.5658 | 24.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 827.6439 | 25.14 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 827.6842 | 26.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 829.5187 | 23.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 829.5526 | 23.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 829.5814 | 24.58 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 829.6634 | 25.9 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 831.5044 | 24.25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 831.5151 | 23.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 831.5664 | 24.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 831.5972 | 24.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 833.5211 | 24.44 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 833.5232 | 24.49 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 833.5825 | 25.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 833.6132 | 25.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 834.5241 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 835.5339 | 24.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 835.5344 | 26.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 835.5346 | 24.75 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 835.5361 | 25.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 836.6256 | 25.58 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 837.5265 | 25.14 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 837.5482 | 25.28 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 837.5494 | 26.12 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 837.5524 | 25.48 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 837.5550 | 24.67 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 839.5666 | 26.76 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 839.6001 | 24.82 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 841.2244 | 21.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 841.5252 | 24.65 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 841.6188 | 25.35 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 841.6505 | 25.57 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 843.5224 | 23.93 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 843.5443 | 25.22 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 843.6778 | 26.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 844.2213 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 845.5379 | 24.25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 845.5607 | 25.32 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 845.5711 | 25.49 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 845.5720 | 25.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 845.5732 | 25.5 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 845.6525 | 26.03 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 847.4477 | 24.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 847.5109 | 23.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 847.5537 | 24.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 850.2383 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 851.5033 | 24.35 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 851.5629 | 24.27 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 853.5065 | 24.76 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 853.5809 | 24.46 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 853.6608 | 25.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 855.1341 | 1.03 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 855.5974 | 25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 855.5984 | 24.75 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 855.6791 | 26.03 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 857.5151 | 24.37 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 857.5171 | 25.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 857.6046 | 25.23 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 858.6805 | 26.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 859.5114 | 24.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 859.5333 | 24.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 859.5954 | 25.31 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 859.6299 | 25.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 861.5432 | 25.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 861.5494 | 25.1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 861.6142 | 23.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 861.8802 | 23.17 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 866.5102 | 24.24 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 866.5136 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 866.5806 | 23.86 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 866.5817 | 23.53 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 871.5531 | 24.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 872.2860 | 13.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 873.5697 | 24.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 873.6814 | 25.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 874.5228 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 875.4908 | 24.31 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 875.5811 | 25.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 877.5769 | 24.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 878.5274 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 879.5198 | 26.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 879.5261 | 24.92 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 879.5846 | 24.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 881.5359 | 25.56 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 881.5755 | 24.74 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 881.6050 | 24.97 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 881.6055 | 25.12 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 882.5339 | 23.71 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 883.4976 | 24.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 884.5468 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 885.5163 | 24.74 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 887.5259 | 24.1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 891.5425 | 24.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 895.5510 | 24.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 897.5652 | 24.58 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 897.6508 | 25.9 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 899.5018 | 24.24 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 899.5539 | 24.65 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 899.5836 | 24.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 900.4300 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 901.5078 | 24.44 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 901.5645 | 25.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 901.5996 | 25.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 903.2686 | 8.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 903.5133 | 24.69 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 903.5173 | 24.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 903.5214 | 24.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 905.5136 | 25.13 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 905.5304 | 25.28 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 905.5330 | 25.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 905.5359 | 25.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 907.5840 | 24.89 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 909.2094 | 21.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 909.5185 | 24.65 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 911.5204 | 23.91 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 911.5408 | 25.22 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 911.6105 | 24.99 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 913.5259 | 24.25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 913.6437 | 25.57 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 915.5400 | 24.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 915.6027 | 25.9 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 919.5462 | 24.27 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 921.4818 | 24.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 921.4939 | 24.75 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 921.5671 | 24.46 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 923.5797 | 25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 923.5804 | 24.74 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 923.5807 | 25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 923.6668 | 26.04 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 925.5018 | 24.37 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 925.5068 | 25.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 925.6043 | 25.31 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 926.6696 | 26.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 927.4907 | 24.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 927.5197 | 26.11 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 927.5214 | 24.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 927.5805 | 25.31 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 927.6164 | 25.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 927.6561 | 26.08 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 929.5380 | 25.1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 931.5949 | 25.57 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 935.5390 | 24.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 937.6426 | 25.1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 939.5400 | 24.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 939.6587 | 25.89 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 939.6611 | 25.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 939.6615 | 25.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 940.2732 | 13.19 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 941.5562 | 24.81 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 941.6253 | 26.04 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 941.6787 | 26.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 943.5716 | 25.43 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 945.4847 | 24.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 945.5622 | 24.4 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 945.6156 | 26.08 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 946.5147 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 947.5084 | 26.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 947.5132 | 24.91 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 949.5230 | 25.56 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 950.5167 | 23.71 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 951.4835 | 24.52 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 952.5339 | 24.02 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 953.5034 | 24.72 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 955.2018 | 1.36 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 955.5001 | 24.1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 955.5518 | 25.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 956.9793 | 0.62 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 957.6074 | 25.89 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 957.6128 | 25.89 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 957.6142 | 25.7 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 957.6156 | 25.7 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 959.6354 | 26.68 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 963.5334 | 24.34 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 965.2370 | 8.51 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 965.4946 | 24.96 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 965.5516 | 24.57 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 967.5697 | 24.97 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 968.4165 | 13.18 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 969.4948 | 24.45 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 969.5589 | 25.15 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 969.5861 | 25.61 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 970.1914 | 1 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 971.5081 | 24.97 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 973.5242 | 25.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 975.4965 | 24.25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 975.6077 | 23.69 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 977.5061 | 24.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 979.4988 | 23.91 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 979.5164 | 25.23 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 981.5126 | 24.24 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 983.5266 | 24.66 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 989.4696 | 24.6 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 989.5490 | 24.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 992.1731 | 1.01 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 993.5804 | 25.31 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 994.6575 | 26.47 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 995.4841 | 24.59 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 995.5109 | 24.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 995.5661 | 25.31 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 995.6009 | 25.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | 1938.9847 | 24.45 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | GDPMANNOSE (CAS# ); (M-H)- | 0.8 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | N-ALPHA-ACETYL-L-ASPARAGINE (CAS# 4033-40-3); (M-H)- | 0.89 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | (S)-2-AMINO-3-(3-HYDOXY-4-OXO-4H-PYRIDIN-1-YL)PROPANOATE OR L-MIMOSINE (CAS# 500-44-7); (M-H)- | 0.92 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | URACIL 5-CARBOXYLATE (CAS# 23945-44-0); (M-H)- | 1.25 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | PROPENOATE (CAS# 79-10-7); (M-H)- | 1.4 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | UDP-N-ACETYL-D-GLUCOSAMINE (CAS# 528-04-1); (M-H)- | 1.42 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | ZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)- | 3.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | ZEATIN [ISTD] (CAS# 13114-27-7); (M-H)- | 3.87 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | (S)-3-METHYL-2-OXOPENTANOATE (CAS# 1460-34-0); (M-H)- | 4.39 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
AN001063 | N-ACETYL-L-LEUCINE (CAS# 1188-21-2); (M-H)- | 7.23 | Minutes | ST000689 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |